777 results on '"Krance, Robert A"'
Search Results
2. Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival
3. Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma
4. A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation
5. Imlifidase Utilization in Glanzmann Thrombasthenia with Anti-GPIIb/IIIa and Anti-HLA Alloimmunization and Severe Platelet Refractoriness following Hematopoietic Stem Cell Transplant.
6. Prolonged Cytopenias after Immune Effector Cell Therapy and Lymphodepletion in Patients with Leukemia, Lymphoma, and Solid Tumors
7. Matched related hematopoietic cell transplant for sickle cell disease with alemtuzumab: the Texas Children’s Hospital experience
8. Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients
9. Antigen-specific T cell responses correlate with decreased occurrence of acute GVHD in a multicenter contemporary cohort
10. Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients
11. Toward Functional Immune Monitoring in Allogeneic Stem Cell Transplant Recipients
12. Reduced Cumulative Dosing of Alemtuzumab in Patients with Hemophagocytic Lymphohistiocytosis (HLH) Is Associated with Improved Long Term Survival
13. Analyzing the Effects of Obesity and Ethnicity on Outcomes of Pediatric Patients with Hematologic Malignancies Receiving Haploidentical Stem Cell Transplant with Post-Transplant Cyclophosphamide (PTCy): A Single Center Experience
14. Long-Term Follow-up of Outcomes of Hematopoietic Stem Cell Transplantation for Patients with Fanconi Anemia: A Single Center Retrospective Review
15. Long-Term Follow-up of Outcomes of Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia: A Single Center Retrospective Review Spanning More Than 25 Years.
16. Acute Exacerbation of Graft-versus-Host Disease following SARS-CoV2 infection after Hematopoietic Stem Cell Transplant in Two Pediatric Patients.
17. Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab
18. Should posttransplant cyclophosphamide be considered standard of care for pediatric transplantation of acute leukemia?
19. Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients
20. “Mini” bank of only 8 donors supplies CMV-directed T cells to diverse recipients
21. Outcomes after Hematopoietic Stem Cell Transplantation for Children with I-Cell Disease
22. Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab.
23. Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia
24. Abstract 4 Excellent Event-Free-Survival and Immunoglobulin Independence for Patients with Severe Combined Immunodeficiency Transplanted with Umbilical Cord Blood Stem Cells
25. High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease
26. Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis
27. Current Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphocytic Leukemia: Success, Failure and Future Perspectives—A Single-Center Experience, 2008 to 2016
28. Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
29. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2
30. Factors Impacting Time to Engraftment in Patients With High-risk Neuroblastoma Following Autologous Stem Cell Transplant
31. Prospective assessment of risk biomarkers of sinusoidal obstruction syndrome after hematopoietic cell transplantation
32. Data from T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor–Expressing T Cells
33. Supplementary Data from T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor–Expressing T Cells
34. Supplementary Tables 1 - 2 from Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity
35. Supplementary Figure 1 from Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity
36. Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes
37. Incidence and Outcome of Secondary Graft Failure in Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia: A Single Center Study
38. Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting
39. Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies
40. Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation
41. 2161. Posoleucel, an Allogeneic, Off-the-Shelf Multi-Virus Specific T Cell Therapy, for Severe, Drug-Refractory Viral Infections in Pediatric Patients Following HCT: Results from a Phase 2 Trial
42. Poor Outcomes Among Pediatric Non-Down Syndrome Acute Megakaryocytic Leukemia Patients Irrespective of Receipt of Hematopoietic Stem Cell Transplant
43. Radiation Therapy to the Primary and Postinduction Chemotherapy MIBG-Avid Sites in High-Risk Neuroblastoma
44. Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study
45. Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis Congenita
46. Donor-derived multiple leukemia antigen–specific T-cell therapy to prevent relapse after transplant in patients with ALL
47. Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia
48. Acute exacerbation of graft‐versus‐host disease following SARS‐CoV2 infection after hematopoietic stem cell transplant in two pediatric patients
49. Donor-Derived Adoptive T-Cell Therapy Targeting Multiple Tumor Associated Antigens to Prevent Post-Transplant Relapse in Patients with ALL
50. Safety and Tolerability of Administering Leukemia-Specific Donor T Cells (mLSTs) after Allogeneic Transplant to Pediatric Patients with AML/MDS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.